Source:http://linkedlifedata.com/resource/pubmed/id/20596793
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-25
|
pubmed:abstractText |
Adrenomedullin 2/intermedin (AM2/IMD) is a new member of the calcitonin/calcitonin gene-related peptide (CGRP) family. CGRP, adrenomedullin (AM), and AM2/IMD share the receptor system consisting of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP). The CRLR/RAMP2 or CRLR/RAMP3 complex forms the AM receptor, whereas the CRLR/RAMP1 forms the CGRP receptor. AM2/IMD binds non-selectively to all three CRLR/RAMP complexes. AM2/IMD has various actions, such as a potent vasodilator action and a protective action against oxidative stress, like AM and CGRP. When administered intracerebroventricularly, AM2/IMD stimulates the sympathetic nervous system and increases blood pressure. In human hypothalamus, AM2/IMD is expressed in the paraventricular and supraoptic nuclei and colocalized with arginine vasopressin. Anterior pituitary cells were diffusely immunostained for AM2/IMD. AM2/IMD stimulates the release of ACTH, prolactin, and oxytocin, but suppresses GH release. Some of these pituitary actions of AM2/IMD have been supposed to be mediated by an unidentified unique receptor for AM2/IMD. In the adrenal gland, immunoreactive (IR)-AM2/IMD and IR-AM were detected in the medulla, while the degree of IR-AM2/IMD and IR-AM in the cortex was relatively weak or undetectable. Furthermore, AM2/IMD and AM were expressed in adrenocortical tumors, such as aldosterone-secreting adenomas, and pheochromocytomas. CRLR and RAMPs are expressed in the hypothalamus, pituitaries, adrenal glands, and adrenal tumors. Thus, AM2/IMD is expressed in every endocrine organ of the hypothalamo-pituitary-adrenal axis together with its receptor. AM2/IMD may act as a neurotransmitter or modulator in the brain and as a paracrine/autocrine regulator in the hypothalamo-pituitary-adrenal axis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ADM2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Calcitonin Receptor-Like Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Multiprotein Complexes,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Activity-Modifying Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenomedullin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1559-1166
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
182-92
|
pubmed:meshHeading |
pubmed-meshheading:20596793-Animals,
pubmed-meshheading:20596793-Brain,
pubmed-meshheading:20596793-Calcitonin Receptor-Like Protein,
pubmed-meshheading:20596793-Humans,
pubmed-meshheading:20596793-Hypothalamo-Hypophyseal System,
pubmed-meshheading:20596793-Multiprotein Complexes,
pubmed-meshheading:20596793-Peptide Hormones,
pubmed-meshheading:20596793-Pituitary-Adrenal System,
pubmed-meshheading:20596793-Receptor Activity-Modifying Proteins,
pubmed-meshheading:20596793-Receptors, Adrenomedullin,
pubmed-meshheading:20596793-Tissue Distribution
|
pubmed:year |
2011
|
pubmed:articleTitle |
Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.
|
pubmed:affiliation |
Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan. ktaka-md@med.tohoku.ac.jp
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|